Lost Money on ESSA Pharma Inc.(EPIX)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into ESSA Pharma Inc. (NASDAQ:EPIX) for potential violations of federal securities laws. This follows ESSA's announcement of ending its Phase 2 trial for a prostate cancer treatment.
November 12, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ESSA Pharma Inc. is under investigation by Levi & Korsinsky for potential securities law violations after halting a Phase 2 trial for a prostate cancer treatment.
The investigation by Levi & Korsinsky into potential securities law violations is likely to negatively impact investor confidence in ESSA Pharma. The halting of a Phase 2 trial suggests potential issues with the drug's development, which could further affect the stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100